Literature DB >> 30265175

Increased inflammatory responsiveness of peripheral blood mononuclear cells (PBMCs) to in vitro NOD2 ligand stimulation in patients with ankylosing spondylitis.

Negar Vanaki1,2, Taghi Golmohammadi1, Ahmadreza Jamshidi2, Maryam Akhtari2,3, Mahdi Vojdanian2, Shayan Mostafaei2, Shiva Poursani2, Nooshin Ahmadzadeh2, Mahdi Mahmoudi2.   

Abstract

Background: Ankylosing spondylitis (AS) is a common debilitating rheumatic disease in which the innate immune components especially the Interleukin (IL)-23/IL-17 axis related genes play important role in its pathogenesis. Nucleotide binding oligomerization domain-containing protein (NOD)2, as an innate receptor, is critical for IL-23 production in cells. Therefore, we aimed to stimulate NOD2 signaling and study its effects on cytokine production in peripheral blood mononuclear cells (PBMC) of these patients.
Methods: PBMCs from 18 patients with active AS and 18 healthy individuals were separated by Ficoll-Hypaque density gradient centrifugation and cultured in the presence of muramyl dipeptide (MDP), as NOD2 ligand. Quantitative expression analysis of NOD1, NOD2, RIPK2, SLC15A4, NLRP1, NLRP3, IL23A, IL17A, IL1B, and TNFA genes was performed using Real-time polymerase chain reaction (PCR). Finally, protein changes of IL23A and IL17A expression were validated using enzyme linked immunosorbent assay (ELISA).
Results: Apart from NOD1 that tend to be downregulated in the controls, all the selected genes showed overexpression in response to MDP in cells from the studied groups. Except RIPK2, all the genes had higher expression changes upon MDP stimulation in the AS population. Overexpression of IL23A and IL17A were confirmed at protein levels using ELISA. The strong positive correlation between NLRP3 and NOD2 was decreased after stimulation but new correlations between NLRP3 and IL1B, RIPK2 and SLC15A4 were observed after treatment. Conclusions: This study indicated that AS PBMCs were hyper-responsive to MDP stimulation. This observation implies an important role of NOD2 in the pathogenesis of inflammatory diseases including AS.

Entities:  

Keywords:  Ankylosing spondylitis; NOD2; PBMC

Mesh:

Substances:

Year:  2018        PMID: 30265175     DOI: 10.1080/08923973.2018.1510963

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  4 in total

1.  Activation of the Endoplasmic Reticulum Stress Response Impacts the NOD1 Signaling Pathway.

Authors:  Jonathan M Mendez; Lakshmi Divya Kolora; James S Lemon; Steven L Dupree; A Marijke Keestra-Gounder
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis.

Authors:  Hongyan Qian; Rongjuan Chen; Bin Wang; Xiaoqing Yuan; Shiju Chen; Yuan Liu; Guixiu Shi
Journal:  Front Pharmacol       Date:  2020-11-06       Impact factor: 5.810

3.  Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis.

Authors:  Junlai Wu; Lifang Yan; Kexia Chai
Journal:  J Clin Lab Anal       Date:  2021-08-21       Impact factor: 2.352

Review 4.  Emerging Roles of Long Non-Coding RNAs in Ankylosing Spondylitis.

Authors:  Ruifu Sun; Xuesong Wang; Xiaohong Sun; Bing Zhao; Xiugong Zhang; Xiaojin Gong; Sunny Hei Wong; Matthew Tak Vai Chan; William Ka Kei Wu
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.